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ABSTRACT 
 
Objective: To evaluate the association of short-term variation (STV) of the fetal 
heart rate in predicting fetal acidaemia at birth. 
Methods: The search strategy employed searching of electronic databases 
(MEDLINE, Web of Science, Scopus, and Google Scholar) and reference lists of 
relevant studies. Data was extracted from studies, adhering strictly to the following 
criteria: singleton pregnancy at ≥ 24 weeks gestation, computerised CTG (index test) 
and calculation of STV before delivery. The outcome measure was arterial pH 
assessed in cord blood obtained at birth. 
Results: Meta-analysis showed moderate accuracy of STV in predicting fetal 
acidaemia with a sensitivity of 0.57 (95% CI: 0.45 to 0.68), specificity of 0.81 (95% 
CI: 0.69 to 0.89), positive likelihood ratio of 3.14 (95% CI: 2.13 to 4.63) and negative 
likelihood ratio of 0.58, (95% CI: 0.46 to 0.72). However, in intra-uterine growth 
restricted fetuses, a small improvement in detecting acidaemia was observed; with a 
sensitivity of 0.63, (95% CI: 0.49 to 0.75) and negative likelihood ratio of 0.50, (95% 
CI: 0.31 to 0.80). 
Conclusion: STV appears to be a moderate predictor for fetal acidaemia. However, 
its usefulness as a stand-alone test in predicting acidaemia in clinical setting remains 
to be determined.  
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Introduction 
Stillbirth is a devastating pregnancy outcome affecting millions of families worldwide 
and with minimal decline in its incidence in 20 years1. Despite advances in obstetric 
care, identifying antenatal fetal surveillance tests that have the highest predictive 
accuracy for fetal risks remains a challenge2-4. Cardiotocography (CTG), also called 
electronic fetal heart rate (FHR) monitoring (EFM), is widely used to assess the in 
utero fetal condition. This assessment can give vital short-term information about 
fetal wellbeing. However, it is subjective and associated with high intra-observer and 
inter-observer variability5. More recently, various computerised systems for objective 
FHR analysis have been developed, one of the most validated and used being the 
Oxford-system6, devised by Dawes, Redman and colleagues in 19827. Currently in 
use today in many antenatal clinics and Day assessment Units, computerised 
systems eliminate observer variability, improve the reproducibility of EFM, and 
determine FHR parameters such as short-term variation (STV) that cannot be 
assessed visually8. 
 
The value of STV has been investigated on its own9,10 or in combination with other 
modalities of fetal surveillance2,11 in predicting fetal acidaemia at birth. Some studies 
suggest that STV is a powerful and reliable indicator of fetal acid base status, fetal 
hypoxemia, and stillbirth12,13. However other reports suggest that it is a poor 
predictor of perinatal outcome9. Possible reasons for the controversy include 
differences in study design and population heterogeneity, varied gestational ages at 
which studies were carried out, non-uniformity in defining acidaemia at birth and 
variable thresholds of STV employed to predict fetal-neonatal acidaemia. Given 
these seeming conflicts in study quality and data interpretation, a comprehensive 
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and systematic review is required to determine the usefulness of STV in predicting 
fetal and neonatal compromise. 
The purpose of this review is to evaluate current literature and establish the strength 
of association of STV with neonatal acidaemia. 
 
Materials and Methods 
Search strategy 
This systematic review was carried out according to the standards set by the Meta-
Analysis of Observational Studies in Epidemiology (MOOSE) group 14 
We conducted an extensive search in Medline (PubMed and Ovid), Google Scholar, 
Web of Science and Scopus from inception until March 2015. For the Medline search 
we used a combination of MeSH headings, such as “Short-term variation” OR “STV” 
AND “Fetal heart rate” OR “FHR”.  
The entire search strategy was limited to human studies published in English. The 
manuscripts were examined for duplicated populations. If any were found we 
selected the most recent and complete version. The search was performed by two 
physicians and a medical school librarian. Bibliographies of relevant retrieved studies 
and recent reviews were hand-searched to identify cited articles not captured by 
electronically. We scrutinised the abstracts identified by the electronic searches and 
obtained full manuscripts of all the citations that were thought to have met the 
inclusion criteria. Two reviewers (HK and RJ) independently examined the 
manuscripts to determine their eligibility for inclusion in the review and assessed 
their quality. Methodological quality was defined as the confidence that the study 
design, conduct, and analysis have minimised biases in estimation of the 
association. The articles were assessed using the complete STARD and QUADS 
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checklists 15,16. These are guidelines for reporting, and methodological quality of 
studies on diagnostic accuracy. We rated the study as being of high quality if it had 
at least four of the following items: adequate description of the population, adequate 
description of computerised CTG using Dawes and Redman criteria for the 
interpretation of FHR parameters in particular STV, duration of FHR tracing and 
record of last assessment prior to delivery, outcome measures defined appropriately, 
prospective recruitment, blinding of the investigators carrying out the outcome 
measure and the statement on assessing the value of STV in predicting perinatal 
outcome. When a study adhered to three or fewer of these criteria we considered it 
to be of medium or low quality. 
 
Data extraction 
We extracted data from the studies, adhering strictly to the following criteria: 
singleton pregnancy at or more than 24 weeks gestation, computerised CTG (index 
test) until the Dawes and Redman criteria for normality were met and calculation of 
STV before delivery; outcome measure being arterial or venous pH or base excess 
assessed in cord blood obtained at birth. Observational studies that allowed 
generation of a 2×2 table (true positives, false positives, false negatives, and true 
negatives) to compute an estimate of the association between STV and neonatal 
acidaemia were included. We excluded studies with five or fewer cases, because of 
unreliability. 
 
Data synthesis 
We used 2x2 tables to calculate point estimates and 95% confidence intervals of 
sensitivity (true positive rate), specificity (true negative rate), positive likelihood ratio 
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(how many times more likely positive index test results were in the acidaemia group 
compared to the non-acidaemia group), and negative likelihood ratio (how many 
times less likely negative index test results were in the acidaemia group compared to 
the non-acidaemia group) for individual studies. When calculating the likelihood 
ratios, where 2×2 tables contained zero cells, 0.5 was added to each cell to enable 
the calculations to be carried out. 
Following the guidance of the Cochrane Collaboration 17 we did not formally test for 
heterogeneity in sensitivity and specificity using the I² statistic. Instead, we assessed 
the magnitude of observed heterogeneity graphically by plotting the sensitivities and 
specificities in the receiver operating characteristic (ROC) space, examining how 
close the observed results lie to the summary ROC curve and the associated 
prediction ellipse. 
We considered study design, study quality, population risk, gestational age at the 
time of index test and differences in cut off value of pH for diagnosing acidaemia as 
potential sources of heterogeneity. Pooled estimates of positive and negative 
likelihood ratios were calculated using the DerSimonian-Liard method 18. A bivariate 
meta-analysis model was used to calculate the pooled estimates of sensitivity and 
specificity and fit a summary ROC curve 19. Using a bivariate model allows the 
correlation that exists between sensitivity and specificity to be incorporated.  
When reason for heterogeneity was identified, we carried out sub-group analyses. 
As clinical heterogeneity was present between studies, we used random effects 
models throughout. 
Analysis was conducted in R (R Core Team) 20 using the mada package 21. 
 
Results: 
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An initial search of 398 citations, identified 7 primary articles 10,11,22-26 reporting on 
diagnostic accuracy of STV and neonatal acidaemia, allowing generation of 2×2 
tables of accuracy (true positives, false positives, false negative, true negatives) for 
individual studies. 
Figure 1 displays the retrieval process of the relevant articles. The selection process 
started by screening the title and abstract to exclude the non-related papers then the 
duplicates were removed electronically. In accordance to the pre-set inclusion and 
exclusion criteria the two reviewers re-evaluated the recruited articles, agreed on the 
included papers and reached consensus regarding inconsistencies. 
 
Table 1 details the study characteristics of the individual studies. There were 7 
studies included 10,11,22-26 that used diagnostic accuracy to establish the value of STV 
in the prediction of neonatal acidaemia. The included studies totalled 780 
pregnancies and reported on arterial cord pH, with thresholds ranging from <7.00 to 
7.25. Computerised CTG was performed and STV was measured within 24 hrs of 
delivery in all except for one study 24 where no such record was found. Five studies 
were performed on high risk pregnancies 10,11,23,25,26, one on low-risk 24 and one 
included both high and low risk populations 22. Amongst high-risk pregnancies, 4 
studies observed a predictive relationship of STV for neonatal acidaemia in intra-
uterine growth restricted (IUGR) fetuses 10,11,23,26. However, all studies excluded 
fetuses with chromosomal and structural anomalies. There were 2 studies using 
retrospective 24,26, 2 consecutive 10,22, 1 prospective 11, 1 cross-sectional 25 and 1 
undefined 23 patient recruitment.  
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Figure 2 shows a summary of the risk of bias and concerns about applicability of the 
included studies assessed using the QUADAS-2 checklist 15. Overall study quality 
was variable, revealing some deficiencies in the reporting. In terms of patient 
selection, 43% (3/7) had a possibility of introducing bias because of a lack of 
information about how patients were enrolled 23-25. One study did not verify the 
duration of STV and time of recording in relation to delivery and this raised concerns 
regarding its applicability to this meta-analysis 24. There was a possible risk of bias 
due to the reference standard in 86% (6/7) studies due to poor reporting of whether 
the reference standard results were interpreted without knowledge of the results of 
the index test. However, all studies contained an adequate description of the 
performance of the STV and outcome measure. Overall, we had concern about the 
applicability of only one study and this was investigated further as part of sensitivity 
analyses 24. 
 
Results for individual studies are summarised in Table 2, the pooled results for the 
positive and negative likelihood ratios are shown in Figure 3, and the pooled results 
for sensitivity and specificity are displayed on summary ROC plots in Figure 4. The 
pooled results show that STV predicts neonatal acidaemia with sensitivity of 0.57 
(95% CI: 0.45 to 0.68) and specificity of 0.81 (95% CI: 0.69 to 0.89). The pooled 
estimate for the positive likelihood ratio was 3.14 (95% CI: 2.13 to 4.63) and the 
pooled estimate for the negative likelihood ratio was 0.58 (95% CI: 0.47 to 0.72). 
 
A number of sensitivity analyses were also conducted to determine how robust the 
pooled results were to studies shown to be outlying on the summary ROC plots as 
well as to any studies that may have introduced bias. The first analysis removed the 
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study of Galazios et al 24, as this was determined most likely to introduce bias and 
had the most concern about applicability. Removing this study gave pooled 
sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio estimates 
of 0.61 (95% CI: 0.51 to 0.71), 0.75 (95% CI: 0.67 to 0.82), 2.64 (95% CI: 1.94 to 
3.60) and 0.52 (95% CI: 0.41 to 0.67) respectively. The second analysis removed the 
two outlying studies with sensitivity of 1, Guzman et al 10 and Anceschi et al 23. 
Removing these studies gave pooled sensitivity, specificity, positive likelihood ratio, 
and negative likelihood ratio estimates of 0.53 (95% CI: 0.39 to 0.66), 0.84 (95% CI: 
0.69 to 0.93), 3.13 (95% CI: 1.88 to 5.21) and 0.62 (95% CI: 0.53 to 0.72) 
respectively. 
 
Due to clinical heterogeneity between the populations studied, subgroup analysis 
was performed on the four studies with IUGR 10,11,23,26. The pooled results from this 
high-risk population show that STV predicts neonatal acidaemia with a sensitivity of 
0.63 (95% CI: 0.49 to 0.75), specificity of 0.72 (95% CI: 0.61 to 0.82), positive 
likelihood ratio of 2.62 (95% CI: 1.71 to 4.03), and negative likelihood ratio of 0.50 
(95% CI: 0.31 to 0.80). Due to the small number of studies we were unable to 
conduct any sensitivity analyses for this subgroup. We also considered 
heterogeneity due to differences in cut-off value of pH for diagnosing acidaemia and 
difference in cut-off values for STV in predicting outcome. However, visual checks of 
sensitivity and specificity did not reveal any evidence of a threshold effect. 
 
Discussion 
For the prediction of fetal acidaemia, STV was found to have an overall moderate 
predictive accuracy with a sensitivity of 0.57 (95% CI: 0.45 to 0.68), specificity of 
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0.81 (95% CI: 0.69 to 0.89), positive likelihood ratio of 3.14 (95% CI: 2.13 to 4.63) 
and negative likelihood ratio of 0.58 (95% CI: 0.46 to 0.72). However, in fetuses with 
IUGR, there was a small improvement in the sensitivity (0.63, 95% CI: 0.49 to 0.75) 
and negative likelihood ratio (0.50, 95% CI: 0.31 to 0.80) of detecting acidaemia, but 
small decrease in specificity (0.72, 95% CI: 0.61 to 0.82) and positive likelihood ratio 
(2.62, 95% CI: 1.71 to 4.03). 
The strength of our review and the validity of our inferences lie in the methodology 
used. We complied with existing guidelines for the reporting of systematic reviews of 
diagnostic 27 and observational studies 14 evaluating causal association. Our 
literature searches were extensive in relevant databases and careful attention was 
paid to assessment of design quality and reporting. We developed this strategy in 
consultation with a medical school librarian, avoiding the chance of missing eligible 
publications. Our review provides the best available evidence, at the present time of 
the association between STV and neonatal acidaemia. 
The studies we pooled had heterogeneity in terms of quality, population risk, 
threshold for STV and neonatal acidaemia. In order to tackle this problem, we carried 
out recommended analyses, including bivariate analysis and sub-group meta-
analysis with pooled sensitivities and specificities 28,29.  
The limitations of our review lie mainly in the lack of clear reporting within individual 
studies and in the residual heterogeneity despite sub-group analysis. It is accepted 
that poor study design and conduct may affect the estimates of diagnostic accuracy 
30,31, but it is not entirely clear how individual aspects of quality may affect accuracy 
and to what magnitude. To overcome this problem, each individual paper must be 
assessed, ideally by meta-regression 32 using items of study quality. Due to small 
sample size of primary studies, it was not possible to apply meta-regression, thus 
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sub-group analysis using a random effects model was performed to account for 
heterogeneity and underpowered studies and no significant difference was observed. 
Furthermore, we pooled sensitivities and specificities which are less susceptible to 
variations in prevalence 29 and are more useful in determining the probability of 
having a problem, following the test. These strategies enabled us to perform meta-
analysis, despite the presence of heterogeneity among the selected studies. 
The quality of primary studies varied. Anceshi et al22 evaluated 195 singleton 
pregnancies and studied STV between 26 and 42 weeks gestation. They observed 
that within the group of pregnant women below 34 weeks of gestation, STV less than 
5.1ms was a significant predictor of acidemia (Sensitivity of 100%, Specificity of 
61%;P<0.05), whereas for the whole group, sensitivity was 62.5% and specificity 
was 78.5%. Similar results were observed in their study on 24 preterm IUGR fetuses 
23, where STV less than 4.5ms predicted acidaemia with a sensitivity of 100% and 
specificity of 70%.  
Guzman et al 10 and Serra et al 26 studied IUGR fetuses between 26 and 42 
gestational age. In agreement with the above authors they found STV <3.5ms and 
<4.7ms as significant predictors of neonatal acidemia. In contrast to the above 
studies, Turan et al 11 attempted to integrate STV with the venous Doppler and the 
biophysical profile score in 58 IUGR fetuses. They found that although STV <3.5ms 
predicted neonatal acidemia with of sensitivity 47% and specificity of 83%, but when 
combined with Doppler studies, the sensitivity increased to 56% and specificity 
decreased to 79%.  
Galazios et al 24 reported their results on 167 uncomplicated pregnancies. They 
found that STV <5ms predicted neonatal acidemia with sensitivity of 34% and 
specificity of 96.6%. Although they included a large number of cases, their definition 
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of acidemia was considered at pH <7.25, which is much higher compared to other 
studies, and necessitating caution in interpreting their results. 
Garcia et al 25 observed that STV threshold of 5.25ms predicted acidaemia with a 
sensitivity of 57.1% and a specificity of 85.2% in 41 pregnant women with 
hypertensive disorder. However, the study did not address and investigate the 
confounding and known influence of various drugs such as hydralazine and 
magnesium sulphate on FHR and its variation 33. Therefore, it is difficult to establish 
whether the observed changes in STV truly reflected in-utero hypoxia or affected by 
other confounding factors. 
It is difficult to draw definitive conclusion based on the studies included for this 
review and to answer the following questions: 
 Does STV reliably predicts neonatal acidaemia or not? 
 Is STV a better marker for detecting acidaemia in high-risk pregnancies, in 
particular IUGR, compared to low-risk pregnancies? 
 Does STV predict acidaemia in high-risk preterm fetuses compared to term? 
 Does STV performs better when combined with other modalities of fetal 
surveillance? 
This review has highlighted gaps in literature and stresses the importance of 
exploring further areas of study design that will be vital to answer these questions.  
FHR variability is known to depend on several factors such as gestational age 34. It is 
well understood that STV increases as gestational age progresses, reflecting 
development of fetal autonomic nervous system (ANS) and maturation of vagal 
innervation to the fetal heart 34,35. None of the studies, except for one 22 divided their 
study group into subgroups according to gestational age. Furthermore, all studies 
included in this review, except for two 10,26 measured STV for a duration of 40 
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minutes or even less. It is well known from previous research that a healthy fetus can 
remain in quiet sleep for up to 50 minutes with an unreactive, low FHR variation 5,36. 
Studies of STV that include fetal monitoring for longer periods of time are therefore 
required to determine its true predictive accuracy for fetal acidemia. Moreover, the 
period of time between the determination of fetal heart STV and fetal delivery varied 
significantly between studies and subjects. Further studies are therefore required to 
determine the optimum timing of STV assessment for predicting fetal acidemia 
before its clinical utility and more widespread adoption can be ascertained. 
 
In conclusion, the results of this meta-analysis highlight the need for high quality 
primary studies of STV predictive accuracy for fetal acidaemia. Furthermore, its 
place in assessing the fetus at risk of acidaemia in clinical care, singly or in 
conjunction with current surveillance techniques remains to be determined. Such 
studies need to include other surveillance techniques in clinical practice, as well as 
individual patient data enabling the test to be assessed at an individual level. 
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 Figure 1: Literature retrieval process 
 
106 articles excluded after 
title and abstract screening 
141 Articles excluded after 
duplicate removal 
51 Primary articles included for full text 
screening from electronic searches 
and reference lists 
Online search N= 398 potentially 
relevant article 
38 articles excluded (ineligible outcomes, 
incomplete data, ineligible inclusion criteria, 
and review studies) 
12 full articles included for 
in depth evaluation 
7 original articles included in this 
systematic review 
5 articles excluded 
(Not allowing generation of 2×2 table of 
test accuracy) 
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Figure 2: Bar chart showing quality of evidence on STV in predicting foetal acidemia 
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Figure 3: Forest Plot of STV to predict foetal acidemia with sub-group analysis. 
 
LR+, positive likelihood ratio; LR-, negative likelihood ratio; CI, confidence interval 
Squares represent pooled results, circles represent individual studies. 
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Figure 4: Summary Receiver Operating Characteristic (ROC) Curves for the bivariate analysis of the accuracy of STV to 
predict foetal acidemia.  
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Table 1: Studies included in the systematic review of association between short-term variation in fetal 
heart rate and fetal acidaemia 
Study  
(First author 
and year) 
Study design Population studied No of women 
analysed 
GA at the 
time of test 
(weeks) 
Details of index test Umbilical artery 
acidaemia 
Anceschi et al 
2003 
Consecutive Low and high risk 
population 
 
N=195 
Divided into 
subgroups according 
to GA 
<34 weeks (n=31), 
35-37 weeks (n=37) 
and >37 weeks 
(n=127) 
 
26-42 
 
cCTG performed for 40 min, 4 hrs 
prior to elective-C-section 
 
pH<7.00 
 
Anceschi et al 
2004 
Not defined High risk with IUGR 
fetuses 
N=24 24-35 cCTG performed for 40 min, 2 hrs 
prior to C-section 
pH<7.00 
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Galazios et al 
2010 
Retrospective Low-risk population N=167 38-40 No mention of how long CTG was 
performed and no record of how 
long before delivery,  
pH<7.25 
Garcia et al 
2008 
Cross-
sectional 
High risk with 
hypertensive 
disorder 
N=41 27-41 Duration 20 min, 24 hrs of C-
section  
 
pH<7.20 
Guzman et al 
1996 
Consecutive High risk with IUGR 
fetuses 
N=38  
 
26-37 
 
Duration of recording  1 hr within 
4 hrs of C-section 
pH<7.20 
 
Serra et al 2008 Retrospective High risk with IUGR 
fetuses  
N=257 26-42 cCTG performed for 60 min 
within 24 hrs of delivery 
pH<7.20 for pre-labour 
C-section and 
pH<7.12 for vaginal birth 
and emergency  C-
section 
Turan et al 2007 Prospective High risk with IUGR 
fetuses  
N=58 
 
26-38 Minimum duration of recording 
was 30 min on the day of C-
section 
pH<7.20 
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Table 2: Analysis on STV in predicting fetal acidaemia for individual studies 
 
Study pH STV TP FP FN TN Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Positive  
Likelihood 
Ratio 
(95% CI) 
Negative 
Likelihood 
Ratio 
(95% CI) 
Anceschi, 2003 7.00 5.10 5 40 3 147 0.63 (0.31, 0.86) 0.79 (0.72, 0.84) 2.77 (1.56, 4.91)  0.51 (0.24, 1.10) 
Anceschi, 2004 7.00 4.50 11 4 0 9 1.00 (0.74, 1.00) 0.69 (0.42, 0.87) 2.77 (1.33, 5.76) 0.12 (0.02, 0.78) 
Galazios, 2010 7.25 5.00 17 4 33 113 0.34 (0.22, 0.48) 0.97 (0.92, 0.99) 8.24 (3.23, 21.00) 0.68 (0.56, 0.84) 
Garcia, 2010 7.20 5.25 8 4 6 23 0.57 (0.33, 0.79) 0.85 (0.68, 0.94) 3.26 (1.32, 8.08) 0.53 (0.30, 0.94) 
Guzman, 1996 7.20 3.50 8 6 0 24 1.00 (0.68, 1.00) 0.80 (0.63, 0.91) 4.11 (2.07, 8.18) 0.13 (0.02, 0.83) 
Serra, 2008 7.20 4.70 54 63 26 114 0.68 (0.57, 0.77) 0.64 (0.57, 0.71) 1.88 (1.46, 2.40) 0.51 (0.37, 0.71) 
Turan, 2007 7.20 2.50 8 7 9 34 0.47 (0.26, 0.69) 0.83 (0.69, 0.92) 2.55 (1.16, 5.58) 0.65 (0.41, 1.01) 
 
STV, short-term variation; TP, true positives; FP, false positives; FN, false negatives; TN, true negatives; CI, confidence interval 
